Skip to main content
Industry News
Moderna: COVID-19 vaccine offers 96% protection in teens

Moderna announced the results of a mid-stage trial indicating its COVID-19 vaccine was 96% effective in teens ages 12 to 17 years with no serious adverse effects. The drugmaker said it "is in discussions with regulators about a potential amendment to its regulatory filings."

Full Story: